Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
International Journal of Radiation Oncology, Biology, Physics|September 21, 2025
Industry Sponsorship and Disease Site Focus in Therapeutic Radiopharmaceutical Clinical Trials Over the Past DecadeJackson N Howell, Jacob Wilkes, Nichole M Maughan, et al.
Pancreas|July 14, 2020
A Single-Institution Experience of Induction 5-Fluorouracil, Leucovorin, Irinotecan, and Oxaliplatin Followed by Surgery Versus Consolidative Radiation for Borderline and Locally Advanced Unresectable Pancreatic CancerMichael Cecchini, Joseph A Miccio, Jay Pahade, et al.
Neoplasia (New York, N.Y.)|April 25, 2016
MDM2 Inhibition Sensitizes Prostate Cancer Cells to Androgen Ablation and Radiotherapy in a p53-Dependent MannerFelix Y Feng, Yu Zhang, Vishal Kothari, et al.
Clinical and Translational Radiation Oncology|July 11, 2022
Patient reported outcomes for quality of life (QOL) by Expanded Prostate Cancer Index (EPIC) on average 15 years post treatmentZachary A Seymour, Stephanie Daignault-Newton, P W McLaughlin, et al.
European Urology|May 26, 2015
Duration of Androgen Deprivation Therapy Influences Outcomes for Patients Receiving Radiation Therapy Following Radical ProstatectomyWilliam C Jackson, Matthew J Schipper, Skyler B Johnson, et al.
Palliative & Supportive Care|February 12, 2026
Blood cancer caregivers' communication with clinicians about online cancer informationAlyssa Crowe, Taylor T Vasquez, Kevin B Wright, et al.
Anticancer Research|September 15, 2019
Clinical Outcomes of Head and Neck Cancer Patients Who Undergo Resection, But Forgo Adjuvant TherapyGokoulakrichenane Loganadane, Benjamin H Kann, Henry S Park, et al.
Prostate Cancer and Prostatic Diseases|September 29, 2020
Quantifying treatment selection bias effect on survival in comparative effectiveness research: findings from low-risk prostate cancer patientsJoseph A Miccio, Wesley J Talcott, Vikram Jairam, et al.
International Journal of Radiation Oncology, Biology, Physics|July 27, 2013
Larger maximum tumor diameter at radical prostatectomy is associated with increased biochemical failure, metastasis, and death from prostate cancer after salvage radiation for prostate cancerSkyler B Johnson, Daniel A Hamstra, William C Jackson, et al.
Radiation Oncology (London, England)|July 10, 2013
A prostate-specific antigen doubling time of <6 months is prognostic for metastasis and prostate cancer-specific death for patients receiving salvage radiation therapy post radical prostatectomyWilliam C Jackson, Skyler B Johnson, Darren Li, et al.
Pageof 5